Lantheus to Present at the Jefferies London Healthcare Conference
Lantheus Holdings' (NASDAQ:LNTH) Promising Earnings May Rest On Soft Foundations [Yahoo! Finance]
Lantheus Continues to Commend CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals and Reaffirms Outlook for PYLARIFY’s Blockbuster Status for 2025
Results: Lantheus Holdings, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts [Yahoo! Finance]
Lantheus Holdings, Inc. (NASDAQ: LNTH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.